Full text
PDF





Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Brady L. W., Markoe A. M., Woo D. V., Amendola B. E., Karlsson U. L., Rackover M. A., Koprowski H., Steplewski Z., Peyster R. G. Iodine-125-labeled anti-epidermal growth factor receptor-425 in the treatment of glioblastoma multiforme. A pilot study. Front Radiat Ther Oncol. 1990;24:151–165. doi: 10.1159/000417780. [DOI] [PubMed] [Google Scholar]
- Brady L. W., Markoe A. M., Woo D. V., Rackover M. A., Koprowski H., Steplewski Z., Peyster R. G. Iodine125 labeled anti-epidermal growth factor receptor-425 in the treatment of malignant astrocytomas. A pilot study. J Neurosurg Sci. 1990 Jul-Dec;34(3-4):243–249. [PubMed] [Google Scholar]
- Colcher D., Keenan A. M., Larson S. M., Schlom J. Prolonged binding of a radiolabeled monoclonal antibody (B72.3) used for the in situ radioimmunodetection of human colon carcinoma xenografts. Cancer Res. 1984 Dec;44(12 Pt 1):5744–5751. [PubMed] [Google Scholar]
- Dillman R. O., Shawler D. L., Sobol R. E., Collins H. A., Beauregard J. C., Wormsley S. B., Royston I. Murine monoclonal antibody therapy in two patients with chronic lymphocytic leukemia. Blood. 1982 May;59(5):1036–1045. [PubMed] [Google Scholar]
- Engert A., Martin G., Amlot P., Wijdenes J., Diehl V., Thorpe P. Immunotoxins constructed with anti-CD25 monoclonal antibodies and deglycosylated ricin A-chain have potent anti-tumour effects against human Hodgkin cells in vitro and solid Hodgkin tumours in mice. Int J Cancer. 1991 Sep 30;49(3):450–456. doi: 10.1002/ijc.2910490324. [DOI] [PubMed] [Google Scholar]
- Epenetos A. A., Munro A. J., Stewart S., Rampling R., Lambert H. E., McKenzie C. G., Soutter P., Rahemtulla A., Hooker G., Sivolapenko G. B. Antibody-guided irradiation of advanced ovarian cancer with intraperitoneally administered radiolabeled monoclonal antibodies. J Clin Oncol. 1987 Dec;5(12):1890–1899. doi: 10.1200/JCO.1987.5.12.1890. [DOI] [PubMed] [Google Scholar]
- Esteban J. M., Colcher D., Sugarbaker P., Carrasquillo J. A., Bryant G., Thor A., Reynolds J. C., Larson S. M., Schlom J. Quantitative and qualitative aspects of radiolocalization in colon cancer patients of intravenously administered MAb B72.3. Int J Cancer. 1987 Jan 15;39(1):50–59. doi: 10.1002/ijc.2910390110. [DOI] [PubMed] [Google Scholar]
- Hamilton R. G. Monoclonal antibodies in the diagnosis and treatment of human diseases. Ann Biol Clin (Paris) 1989;47(10):575–581. [PubMed] [Google Scholar]
- Hertler A. A., Frankel A. E. Immunotoxins: a clinical review of their use in the treatment of malignancies. J Clin Oncol. 1989 Dec;7(12):1932–1942. doi: 10.1200/JCO.1989.7.12.1932. [DOI] [PubMed] [Google Scholar]
- Hird V., Stewart J. S., Snook D., Dhokia B., Coulter C., Lambert H. E., Mason W. P., Soutter W. P., Epenetos A. A. Intraperitoneally administered 90Y-labelled monoclonal antibodies as a third line of treatment in ovarian cancer. A phase 1-2 trial: problems encountered and possible solutions. Br J Cancer Suppl. 1990 Jul;10:48–51. [PMC free article] [PubMed] [Google Scholar]
- Jain R. K. Transport of molecules across tumor vasculature. Cancer Metastasis Rev. 1987;6(4):559–593. doi: 10.1007/BF00047468. [DOI] [PubMed] [Google Scholar]
- Jansen F. K., Blythman H. E., Carrière D., Casellas P., Gros O., Gros P., Laurent J. C., Paolucci F., Pau B., Poncelet P. Immunotoxins: hybrid molecules combining high specificity and potent cytotoxicity. Immunol Rev. 1982;62:185–216. doi: 10.1111/j.1600-065x.1982.tb00394.x. [DOI] [PubMed] [Google Scholar]
- Jones D. H., Goldman A., Gordon I., Pritchard J., Gregory B. J., Kemshead J. T. Therapeutic application of a radiolabelled monoclonal antibody in nude mice xenografted with human neuroblastoma: tumoricidal effects and distribution studies. Int J Cancer. 1985 Jun 15;35(6):715–720. doi: 10.1002/ijc.2910350604. [DOI] [PubMed] [Google Scholar]
- Kemshead J. T., Jones D. H., Lashford L., Prichard J., Gordon I., Breatnach F., Coakham H. B. 131-I coupled to monoclonal antibodies as therapeutic agents for neuroectodermally derived tumors: fact or fiction? Cancer Drug Deliv. 1986 Winter;3(1):25–43. doi: 10.1089/cdd.1986.3.25. [DOI] [PubMed] [Google Scholar]
- Lashford L. S., Hancock J. P., Kemshead J. T. Meta-iodobenzylguanidine (mIBG) uptake and storage in the human neuroblastoma cell line SK-N-BE(2C). Int J Cancer. 1991 Jan 2;47(1):105–109. doi: 10.1002/ijc.2910470119. [DOI] [PubMed] [Google Scholar]
- Lee Y. S., Bullard D. E., Wikstrand C. J., Zalutsky M. R., Muhlbaier L. H., Bigner D. D. Comparison of monoclonal antibody delivery to intracranial glioma xenografts by intravenous and intracarotid administration. Cancer Res. 1987 Apr 1;47(7):1941–1946. [PubMed] [Google Scholar]
- Lewis I. J., Lashford L. S., Fielding S., Flower M. A., Ackery D., Kemshead J. A phase I/II study of 131I mIBG in chemo-resistant neuroblastoma. The United Kingdom Children's Cancer Study Group (UKCCSG). Prog Clin Biol Res. 1991;366:463–469. [PubMed] [Google Scholar]
- Moseley R. P., Davies A. G., Richardson R. B., Zalutsky M., Carrell S., Fabre J., Slack N., Bullimore J., Pizer B., Papanastassiou V. Intrathecal administration of 131I radiolabelled monoclonal antibody as a treatment for neoplastic meningitis. Br J Cancer. 1990 Oct;62(4):637–642. doi: 10.1038/bjc.1990.345. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pizer B., Papanastassiou V., Hancock J., Cassano W., Coakham H., Kemshead J. A pilot study of monoclonal antibody targeted radiotherapy in the treatment of central nervous system leukaemia in children. Br J Haematol. 1991 Apr;77(4):466–472. doi: 10.1111/j.1365-2141.1991.tb08611.x. [DOI] [PubMed] [Google Scholar]
- Press O. W., Eary J. F., Badger C. C., Martin P. J., Appelbaum F. R., Nelp W. B., Krohn K. A., Fisher D., Porter B., Thomas E. D. High-dose radioimmunotherapy of B cell lymphomas. Front Radiat Ther Oncol. 1990;24:204–227. [PubMed] [Google Scholar]
- Shapiro B., Copp J. E., Sisson J. C., Eyre P. L., Wallis J., Beierwaltes W. H. Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases. J Nucl Med. 1985 Jun;26(6):576–585. [PubMed] [Google Scholar]
- Zalutsky M. R., Noska M. A., Colapinto E. V., Garg P. K., Bigner D. D. Enhanced tumor localization and in vivo stability of a monoclonal antibody radioiodinated using N-succinimidyl 3-(tri-n-butylstannyl)benzoate. Cancer Res. 1989 Oct 15;49(20):5543–5549. [PubMed] [Google Scholar]